A Clinical Study Comparing Calcarea Carbonicum 30C and Natrium Muriaticum 30C in Hypothyroidism

INTERVENTION: Intervention1: Calcarea Carbonica 30C: Prescription based on a detailed case taking of each individual and first follow up is conducted after one week followed by monthly follow up for a period of four months.In each monthly follow up a single dose of Calcarea Carbonica 30C is administered resulting in a total of four doses over the four months of treatment period Control Intervention1: Natrium Muriaticum 30C: Prescription based on a detailed case taking of each individual and first follow up is conducted after one week followed by monthly follow up for a period of four months.In each monthly follow up a single dose of Natrium Muriaticum 30C is administered resulting in a total of four doses over the four months of treatment period CONDITION: Health Condition 1: E039‐ Hypothyroidism, unspecified PRIMARY OUTCOME: To compare the effectiveness of Calcarea carbonica 30C and Natrium muriaticum 30C in the reduction of TSH levelsTimepoint: 4months SECONDARY OUTCOME: To evaluate the changes in Zuleski clinical scoring before and after treatment in both study groupTimepoint: 4months INCLUSION CRITERIA: Patient of both sexes age group of 18‐60years Patient diagnosed with hypothyroidism with elevated TSH levels[4‐10mIU/L] Patient had elevated TSH levels [4‐10mIU/L] and with or without clinical signs and symptoms Patient willing to participate and give informed consent